Dual Therapy With Interferon Beta-1b and Clofazimine for COVID-19
Clinical trial NCT04465695 · UNKNOWN
Trial details
- NCT number
- NCT04465695
- Sponsor
- The University of Hong Kong
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-07-14
- Primary completion
- 2021-06-30
- Enrollment
- 81
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.